IKT
Inhibikase Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD1.67
-0.03 (-1.76%)
Rating:C+
Company Profile
CEO
Mark T. Iwicki
IPO Date
2020-12-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$1.70
Prev. Close
$1.70
Day Low
$1.65
Day High
$1.74
52W Low
$1.33
52W High
$2.26
Market Cap
$0.22B
Volume
0.84M